Bullish case
$19.482 to $22.784
More likely if Select Medical Holdings Corporation shows stronger demand, improving margins or cash flow, and price reclaims resistance with sustained volume.
Select Medical Holdings Corporation research snapshot
SEM AI Stock Analysis
SEM AI stock analysis currently reads Select Medical Holdings Corporation as a specialty healthcare services tied to critical illness recovery, rehabilitation, and outpatient care. The page uses a scenario framework, not a certain price prediction. At the July 7, 2026 cutoff, the quoted price was $16.51, market capitalization was about $2.05 billion, and the main decision point was whether business evidence can offset valuation and execution risk. This is informational research and not investment advice.
Current price
$16.51
Market cap
$2.05 billion
AI score
55 / 100
Rating
Healthcare services value, reimbursement risk
Trend status
Stable but low-momentum setup
Data cutoff (updated weekly)
July 7, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- A-level information richness. Select Medical has long filings, segment data, and mature healthcare services disclosures.
- bias Check
- The AI bias risk is market consensus anchoring because the company is widely covered. The analysis separates quote-verified facts from forward-looking judgments.
- ai Confidence
- High data confidence
- investment Certainty
- Medium-low. The stock can be useful for research screens, but position decisions require first-party filings, live chart data, and personal risk constraints.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Select Medical operates specialty hospitals, rehabilitation hospitals, and outpatient clinics that serve patients needing post-acute or therapy care. | Medium |
| Moat | Moat comes from facility networks, referral relationships, payer contracting, clinical expertise, and local market density. | Medium-high |
| Management | Management quality is visible in facility utilization, payer mix, labor control, and debt management. | Medium |
| Financial trend | Price and market cap were verified mechanically, but full revenue, net income, cash, and debt checks still need two-source financial statement review for SEM. | Source gap noted |
| Valuation | Valuation should be weighed against leverage, reimbursement risk, and normalized free cash flow. | Medium-low |
| Technical trend | Stable but low-momentum setup. Use live moving averages, support, resistance, momentum, volume, and invalidation levels before acting. | Medium |
| Risk level | The thesis can fail if labor costs rise, reimbursement pressure increases, occupancy falls, or leverage limits flexibility. | Medium-high |
| AI confidence | High data confidence for qualitative mapping and quote math. Lower confidence for forward returns. | High data confidence |
| Investment certainty | Medium-low certainty because the page gives a framework, not a personalized buy or sell instruction. | Medium-low |
SEM AI stock forecast
SEM AI Stock Forecast Scenarios
The SEM AI stock forecast uses scenario ranges around the $16.51 quote rather than a point target. The bullish case requires stronger evidence on critical illness recovery, rehabilitation, and outpatient care; the base case assumes mixed execution; the bearish case assumes the main risk path becomes visible.
Base case
$14.529 to $18.821
More likely if fundamentals remain mixed and the stock trades around current expectations while investors wait for the next filing or earnings update.
Bearish case
$9.081 to $12.878
More likely if these risk paths appear: labor costs rise, reimbursement pressure increases, occupancy falls, or leverage limits flexibility, and technical support breaks after the data cutoff.
SEM AI technical analysis
SEM AI Technical Analysis
SEM AI technical analysis starts from the $16.51 quote and the observed volume snapshot of 14,273,973 shares. Because this static page does not fetch request-time chart data, moving averages and live momentum should be confirmed in a charting tool before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $16.51 | Current quote used for this page as of the July 7, 2026 data cutoff. |
| Near support | $15.189 to $16.015 | Estimated from the current quote and recent downside volatility. Treat as a planning zone, not a guaranteed floor. |
| Near resistance | $17.336 to $18.491 | Estimated from the current quote and a normal rebound band. A close above this zone would improve short-term momentum. |
| 50-day moving average | Requires live chart confirmation | Use current chart data before acting. The page does not fetch request-time market data. |
| 200-day moving average | Requires live chart confirmation | Long-term trend confirmation should be checked against a live chart or broker data. |
| Momentum | Stable but low-momentum setup | Volume and price action suggest the setup needs confirmation after the cutoff. |
| Volume | Elevated volume snapshot | The source snapshot showed heavy trading activity, which can amplify false breakouts and breakdowns. |
| Volatility | High monitoring priority | Use position sizing that can tolerate wide daily movement for this ticker. |
| Invalidation | Close below $15.189 | A decisive close below the support zone would weaken the short-term setup. |
SEM AI trading strategy
SEM AI Trading Strategy Framework
The SEM AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and fresh filings or news checks.
Trend-following setup
Wait for SEM to hold above near support and push through the resistance zone with volume that confirms buyer demand.
A close below the support zone or a failed breakout should invalidate the setup.
Mean-reversion setup
If SEM falls into the support band without a thesis break, compare price action with the next earnings, balance sheet, and industry datapoints.
Do not average down without a predefined maximum loss and a fresh review of the business risk.
Fundamental monitor
Track the evidence that matters most for critical illness recovery, rehabilitation, and outpatient care: revenue quality, margin path, capital needs, competitive position, and management execution.
Reduce confidence when price moves are driven by headlines without matching financial evidence.
Investment research summary
Four-master Research Compression
Business essence
Select Medical operates specialty hospitals, rehabilitation hospitals, and outpatient clinics that serve patients needing post-acute or therapy care.
Moat
Moat comes from facility networks, referral relationships, payer contracting, clinical expertise, and local market density.
Munger risk inversion
The thesis can fail if labor costs rise, reimbursement pressure increases, occupancy falls, or leverage limits flexibility.
Management
Management quality is visible in facility utilization, payer mix, labor control, and debt management.
Industry trend
Aging demographics support demand, but reimbursement and labor cycles are key constraints.
Valuation and margin of safety
Valuation should be weighed against leverage, reimbursement risk, and normalized free cash flow.
Source-backed data
SEM Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| SEM price | $16.51 | Current quote snapshot cross-checked with user supplied market scan | July 7, 2026 |
| Market capitalization | $2.05 billion, verified as $16.51 x 124.02 million implied shares | financial_rigor.py market cap verification | July 7, 2026 |
| Exchange | NYSE | User supplied market scan and public quote pages | July 7, 2026 |
| Trading volume snapshot | 14,273,973 | User supplied market scan | July 7, 2026 |
| Financial statement depth | Public filings available, two-source statement checks still required before investment use | Research quality check | July 7, 2026 |
| Scenario valuation input status | EPS, cash, debt, and net income were not fully cross-validated for this batch page | Source gap disclosure | July 7, 2026 |
Frequently Asked Questions
Use Pineify AI Stock PickerBuild an AI trading strategyRun an AI stock screenerRead the NVDA AI stock analysis
This SEM AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 7, 2026, may be incomplete, and can be wrong if new filings, market prices, company events, or macro conditions change.